Acute Disorders of Brain Circulation and Type 2 Diabetes
DOI:
https://doi.org/10.61788/njn.spec.18.8Keywords:
stroke, cerebral circulation disorder, diabetes mellitus, glycosylated hemoglobinAbstract
A study of the state of carbohydrate metabolism in patients with acute disorders of cerebral circulation (ADCC) was carried out. It is established that the development of a stroke is often preceded by a period of hyperglycemia. The level of glycosylated hemoglobin affects the clinical course of a stroke, including the restoration of disturbed neurological functions. The debut of diabetes mellitus (DM) can coincide with the development of ADCC.
References
American Diabetes Association. Standards of Medical Care in Diabetes - 2014. Diabetes Care. 2014; 37: 14-80.
Backman J.A., Creager M.A., Libby P. et al. Diabetes and atherosclerosis. Epidemiology, pathophysiology and management. JAMA 2002; 287: 2570-2581.
Banerjee C., Moon Y.P, Paik M.C. et al. Duration of diabetes and risk of ischemic stroke: The Northern Manhattan Study. Stroke. 2012; 43 (5): 1212-1217.
Heo S.H., Lee S.H., Kim B.J. et al. Does glycated hemoglobin have clinical significance in ischemic stroke patients? Clin Neurol Neurosurg. 2010 Feb; 112 (2): 98-102.
Huisa B.N, Roy G, Kawano J, Schrader R. Glycosylated hemoglobin for diagnosis of prediabetes in acute ischemic stroke patients. Stroke Cerebrovasc Dis. 2013 Nov; 22 (8): 564-567.
International Diabetes Federation, 2013.http://www.idf.org/diabetesatlas по сост. на 27.02. 2014.
Kamouchi M., Matsuki T., Hata J. et al. Prestroke Glycemic Control Is Associated With the Functional Outcome in Acute Ischemic Stroke. Stroke.2011; 42: 2788-2794.
Khaw K., Wareham N. Glycated hemoglobin as a marker of cardiovascular risk. Curr Opin Lipidol. 2006; 17 (6): 637-643.
Laing S.P., Swerdlow A.J., Carpenter L.M. et al. Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes. Stroke. 2003; Feb; 34 (2): 418-421.
Multicenter trial of hemodilution in ischemic stroke-background and study protocol. Scandinavian Stroke Study Group. Stroke. 1985; 16: 885-890.
Myint K., Sinha S., Wareham NJ. et al. Glycated hemoglobin and risk of stroke in people without known diabetes in the European Prospective Investigation into Cancer (EPIC)-Norfolk prospective population study: a threshold relationship? Stroke. 2007; Feb; 38 (2): 271-275.
Peters S.A., Huxley R.R., Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and metaanalysis of 64 cohorts, including 775 385 individuals and 12 539 strokes. Lancet. 2014; Mar 6. [Epub ahead of print].
Sacks D.B., Arnold M., Bakris G.L. et al. National Academy of Clinical Biochemistry. Position statement executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011;34: 1419-1423.
Stöllberger C., Exner I., Finsterer J. et al. Stroke in diabetic and nondiabetic patients: course and prognostic value of admission serum glucose. Ann Med. 2005; 37 (5): 357-364.
Stratton I.M., Adler A.I., Neil H.A. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 National Association of Neurologists
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
